Algae Dynamics Corp. (OTCQB: ADYNF) sees opportunity and greater market share in a soon to be legalized marijuana industry in Canada.
Marijuana Investing
California Wildfires Torch Cannabis Farms at Height of Harvest Season
Just months before California is poised to legalize recreational marijuana, fatal wildfires tearing through three northern counties have scorched an untold number of cannabis farms.
ChineseInvestors.com, Inc. (CIIX) Poised to be First to Market in China’s Multibillion-Dollar Skin Care Industry with Line of Cannabidiol-Based Products
ChineseInvestors.com (OTCQB: CIIX) is quickly moving into the multibillion-dollar Chinese skin care industry and is introducing its first line of cannabidiol (CBD) based skin care products.
India Globalization Capital (NYSE: IGC) Achieves Breakthrough with Potential to Prevent, Combat Alzheimer’s
India Globalization Capital (NYSE MKT: IGC), a first mover in the cannabis-based combination therapy space, recently announced that it is readying a line of cannabis-based medical dispensary products that target Alzheimer’s disease.
5 CANNABIS BIOTECH STOCKS TO WATCH
These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?
Aurora Cannabis Announces $6 Million Private Placement
Aurora Cannabis Inc. has agreed to a one-time special accommodation for the benefit of its underwriters due to very significant demand for the Bought Deal, to proceed with a concurrent, non-commissioned, non-brokered private placement of up to 2,000,000 units of the Company (the "Units") at a price of $3.00 per Unit (the "Offering").
InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) Biosynthesis Technology Demonstrates Robust Diversity
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast track with its proprietary technology for the microbial biosynthesis of cannabinoids
Skinvisible, Inc. (SKVI) Has Been Delivering its Patented Polymer Technology to Pharmaceuticals & Cosmeceuticals for Close to Two Decades
Invisicare is a patented polymer delivery system that improves the delivery of topically applied skin care products, thereby enhancing the efficacy of the active ingredients.
ABcann Global Puts The 'Green' In Green Rush
Seekingalpha.com recently posted an in-depth article looking at ABcann Global (TSX.V: ABCN OTCQB: ABCCF) and how well positioned it is in this emerging market. It's a great read for those interested in this company that we've identified as one of Canada's Strongest Growers.
EVIO, Inc. (EVIO) Prepares for New Cannabis Testing Rules in California Ahead of January Recreational Legalization
EVIO, Inc. (OTCQB: EVIO) is readying itself for new testing rules in California, which it foresees as the largest cannabis marketplace in the world.
Standout Players Find Varied, Innovative Means of Serving the Marijuana Industry
Standouts in the diverse cannabis industry include Global Payout, Inc. (GOHE)...
Mounting Evidence on Therapeutic Benefits of Cannabis Unleashes Tsunami
Cannabidiol (CBD), a non-psychoactive compound found in the cannabis sativa plant, has shown tremendous promise for broad-ranging medical benefits, and consumers are taking notice.
Marijuana Company of America (MCOA) Uniquely Positioned for Cannabis and Hemp Industry Innovation
In this competitive market, companies such as Marijuana Company of America, Inc. (OTC: MCOA) are successfully carving out a niche for themselves due to a unique strategic approach and business model.
Emblem Announces $25 Million Bought Deal
Emblem Corp. (TSX VENTURE:EMC)(TSX VENTURE:EMC.WT) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase 5,714,300 units (the "Units") and 15,000 convertible unsecured debentures of the Company
Taking Stock of InMed - InMed President and CEO Eric Adams Sits Down For Two In-Depth Interviews
InMed Pharmaceuticals Inc. (CNSX:IN) (OTCMKTS:IMLFF) CEO Eric Adams recently sat down for two separate interviews regarding InMed's proprietary biosynthesis process, their patent filings and their research on using cannabinoids to treat various diseases.